. Medical Product Alert N°2/2020 - Updated version of 01 April - IOPAC Press "Enter" to skip to content

Medical Product Alert N°2/2020 – Updated version of 01 April

Test de dépistage rapide du VIH falsifié circulant dans les régions OMS des Amériques et de l’Afrique This Medical Product Alert relates to a confirmed falsified human immunodeficiency virus (HIV) in vitro diagnostic medical device (IVD) that has been identified circulating in Guyana and Kenya. Through its Please contact your national health authoritiesAll medical products must be obtained from authentic and reliable sources. Their authenticity and condition should be carefully checked.Advice on action to be taken by national health authorities:WHO requests increased scrutiny within the supply chains of all countries, particularly at testing sites (health facilities, community-based), clinical laboratories, medical stores/warehouses, and at the facilities of relevant economic operators (agents,
authorized representatives, distributors, wholesalers, etc.).If falsified test kits with lot numbers HIV7120026 or HIV6120030 are discovered, please do not use.National health authorities are asked to immediately inform WHO, if these falsified products are discovered in their country using the WHO IVD complaint form.If you have any information concerning the manufacture, distribution, or supply of this product, please contact rapidalert@who.intWHO Global Surveillance and Monitoring System for Substandard and Falsified Medical ProductsFor further information, please visit our website: https://www.who.int/medicines/regulation/ssffc/en/